| John K. Neubert is the CEO of Velocity Laboratories. He received his D.D.S., Orofacial Pain Management specialty training, and Ph.D. from UCLA before completing a clinical fellowship at the National Institutes of Health and obtaining over 10 years of academic experience. He is a co-inventor of the operant orofacial pain assay and is a leading expert in operant pain assessment. He provides a clinician-scientist’s perspective on pain and translational research expertise. |
Robert M. Caudle is the President of Velocity Laboratories. He received his Ph.D. from the University of Illinois at Chicago and completed post-doctoral studies at the University of Washington. After spending 8 years in the Pain and Neurosensory Mechanisms Branch at the National Institutes of Health, he gained over 15 years of academic experience. He is a co-inventor of the operant orofacial pain assay. |
|
Niall P. Murphy, the Chief Scientific Officer for Velocity Laboratories, received his Ph.D. from the University of Cambridge before completing a post-doctoral fellowship at UCLA. He headed an independent laboratory in the RIKEN Brain Science Institute studying addictive processes before adding another 5 years of academic experience at UCLA in a faculty position. He has over 15 years of experience in preclinical models of reward, addiction, motivation, and depression. |
